Syncom Formulations (India) LtdSYNCOMF - focus penny stock lover
Penny stock high risk higher reward
This is my view and it may be biased, do your own analysis
0.28INR
200.71 MINR
2.22 BINR
460.78 M
About SYNCOM FORMULATIONS (INDIA) LT
Sector
CEO
Vijay Shankarlal Bankda
Headquarters
Indore
Website
Employees (FY)
799
Founded
1988
ISIN
INE312C01025
FIGI
BBG000D7VG18
Syncom Formulations (India) Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company operates through the following segments: Pharmaceutical Drugs and Formulations, Trading of Commodities, and Renting of Property. The company was founded by Kedarmal Shankarlal Bankda, Ajay Kumar Bankda, and Vijay Shankarlal Bankda on June 21, 1988 and is headquartered in Indore, India.
BUY TODAY SELL TOMORROW for 5% DON’T HAVE TIME TO MANAGE YOUR TRADES?
- Take BTST trades at 3:25 pm every day
- Try to exit by taking 4-7% profit of each trade
- SL can also be maintained as closing below the low of the breakout candle
Now, why do I prefer BTST over swing trades? The primary reason is that I have observed t
SYNCOMFSyncom Formulations (India) Ltd is in bullish. Small Target in Weekly chart. Target is 13 around.
Trend is healthy.
#SYNCOMF Weekly Chart AnalysisHello, fellow traders and investors! 📊 Let's delve into a thorough analysis of SYNCOMF's weekly chart, unearthing a compelling blend of a demand zone touch, evident RSI support, and the unique considerations of dealing with a micro-cap company. 📈💼
📈 Technical Insights:
✨ Demand Zone Influence: SYNC
SYNCOMFNo fundamental view.
No idea as to how good or bad this company is.
Only Technical view
If starts to stay above 10 we may see some trending moves.
SL can be kept below 8
Syncom Formulations - Multi Year BreakoutSyncom Formulations - Multi year breakout.
Forming a good base, supported with Good Volumes.
*For Educational Purpose and is definitely not a recommendation
~G
Syncom Formula - Chart AnalysisI am learning Technical Analysis and this is for educational purpose.. not to be considered as Recommendation
syncomIn 2040 pharma is booing up , my investment strategy is 70% is stable stocks and remaining ,15% is mind cap ,15 allways in penny stocks
good future for pharma , I find the penny stocks in pharma ,#syncom . now good start to form up trend ,
Syncom formulationRetested trendline on daily timeframe also huge volumes has been seen.
keep holding for long term...fresh entry only after 15.
Target - 50+
4-5 Years
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SYNCOMF is 12.59 INR — it has decreased by 0.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SYNCOM FORMULATIONS (INDIA) LT stocks are traded under the ticker SYNCOMF.
SYNCOMF stock is 3.59% volatile and has beta coefficient of 0.94. Check out the list of the most volatile stocks — is SYNCOM FORMULATIONS (INDIA) LT there?
Yes, you can track SYNCOM FORMULATIONS (INDIA) LT financials in yearly and quarterly reports right on TradingView.
SYNCOMF stock has fallen by 3.30% compared to the previous week, the month change is a 6.69% rise, over the last year SYNCOM FORMULATIONS (INDIA) LT has showed a 103.06% increase.
SYNCOMF net income for the last quarter is 70.02 M INR, while the quarter before that showed 65.12 M INR of net income which accounts for 7.52% change. Track more SYNCOM FORMULATIONS (INDIA) LT financial stats to get the full picture.
Today SYNCOM FORMULATIONS (INDIA) LT has the market capitalization of 11.93 B, it has increased by 12.35% over the last week.
SYNCOM FORMULATIONS (INDIA) LT dividend yield was 0% in 2022, and payout ratio reached 0%. The year before the numbers were 0.28% and 12.38% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, SYNCOMF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNCOM FORMULATIONS (INDIA) LT stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 799.00 employees. See our rating of the largest employees — is SYNCOM FORMULATIONS (INDIA) LT on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNCOM FORMULATIONS (INDIA) LT technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNCOM FORMULATIONS (INDIA) LT stock shows the buy signal. See more of SYNCOM FORMULATIONS (INDIA) LT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNCOM FORMULATIONS (INDIA) LT EBITDA is 261.84 M INR, and current EBITDA margin is 8.28%. See more stats in SYNCOM FORMULATIONS (INDIA) LT financial statements.